MAIA Biotechnology Raises $1.51 Million Through Private Placement with Continued Board Participation, Supporting Financial Runway and Highlighting Insider Conviction Ahead of Phase 3 Trial: MAIA ...
Founded in 2018 and headquartered in Chicago, Illinois, MAIA is a biotechnology company engaged in discovering, developing, and commercializing novel cancer therapies with high unmet medical needs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results